Navigation Links
FDA Approved Mentor® MemoryShape™ Breast Implants Now Offered to Patients at Swan Center for Plastic Surgery
Date:6/19/2013

(PRWEB) June 19, 2013

The US Food and Drug Administration (FDA) announced last week the approval of a third ultra cohesive gel breast implant, Mentor Worldwide’s MemoryShape™.

The FDA approved Sientra/Silimed in March 2012 and Allergan 410 in February 2013. The FDA announced the approval of the MemoryShape™ implant on June 14, 2013. It is approved for primary augmentations in women 22 years old or older and in breast reconstruction of women of any age.

The FDA’s approval comes after six years of data from 955 women participating in trials. Dr. Joseph Bauer of the Swan Center for Plastic Surgery was one of the select plastic surgeons involved in the FDA trials, and he is now pleased to offer the newest breast implants to his patients. Dr. Bauer says, “The Mentor MemoryShape™ ultra cohesive implants are another option for women considering plastic surgery. It’s exciting to have so many options for creating very individualized surgeries.”

All three of the approved ultra cohesive implants require a high level of surgical skill and experience. The Swan Center for Plastic Surgery is a leader in the United States for volume of breast augmentations they perform, and all three staff plastic surgeons are board certified in plastic surgery and helped implement the FDA trial studying the cohesive gel implants. Patients should look for this level of qualifications in the plastic surgeon they choose for their augmentation.

The surgeons at the Swan Center for Plastic Surgery are proponents of educating patients for higher levels of discussion and decision-making and for better expectations for surgical results.

Dr. Bauer comments, “With FDA approval of a third “gummy bear” implant, women have choices for a safe and natural-looking, tear drop shape.”

All three ultra cohesive gel breast implants are offered at The Swan Center for Plastic Surgery.

About The Swan Center:

The Swan Center for Plastic Surgery is a leader in the aesthetic industry specializing in surgery of the breast, body and face.

The Swan Center for Plastic Surgery’s on site operating facility, Alpharetta Aesthetic Center is accredited by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO). The Joint Commission is an independent, not-for-profit organization; and is the nation's oldest and largest standards-setting and accrediting body in health care, focusing on patient safety and quality of care. The plastic surgeons at The Swan Center are board-certified by the American Board of Plastic Surgery, among a multitude of further professional accomplishments.

Swan Center for Plastic Surgery
4165 Old Milton Parkway, Suite 200 East
Alpharetta, GA 30005
http://www.swancenteratlanta.com
(770) 667-0904 or 800-816-1057

Read the full story at http://www.prweb.com/releases/ultra/cohesive/prweb10845621.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. FDA Approved Home Ultrasound Machine Discounted Online
2. Myrtle Beach Urology Groups Administer First Commercial Dose of Newly FDA Approved Prostate Cancer Treatment
3. SafeToSleep Baby Monitor Wins Parent Tested Parent Approved (PTPA) Award
4. South Carolina Association of Veterinarians is Approved Provider of Education for New York Veterinarians and Veterinary Technicians
5. $40 Million Class-Action Skechers Lawsuit Settlement Approved by Federal Judge, Reports Wright & Schulte LLC
6. Wartrol Genital Warts Relief Formula Now Comes With FDA Approved Ingredients for Fast Actions at HerbalRemediezInc.com
7. American Academy of Personal Training Now Approved By The US Department of Education To Offer Low Cost Financial Aid
8. Wartrol Warts Relief Formula Now Comes With FDA Approved Ingredients For Fast Actions
9. FDA Approved Treatment for Painful Intercourse (Dyspareunia) Due to Menopause
10. ASHA Approved Continuing Education Provider HomeCEUConnection.com Announces Two New Live, Interactive Webinars for California Speech-Language Pathologists.
11. EzW2Correction Software Was Approved By SSA To Print W-2C and W-3C On White Paper
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... “Crossing the ... last ten minutes of a woman’s life. “Crossing the Bar” is the creation of ... of three children. , Charlotte, who credits the inspiration of the book to ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... “Some Infallible ... of the Father. “Some Infallible Characteristics of Christ” is the creation of published author, ... of a Baptist Church for thirteen years, a preacher for over nineteen, a pastor ...
(Date:1/22/2017)... Raton, FL (PRWEB) , ... January 22, 2017 , ... ... to customers across the world, recently met with big-name retail buyers at the January ... scientific evidence of efficacy and uses the utmost safety standards in all of its ...
(Date:1/21/2017)... ... January 21, 2017 , ... Caronlab Australia, an Australian company known ... Trade Show in Hilton Head, SC, where it benefited from outstanding meetings with major ... its beauty and wellness products. At this trade show, the company had the chance ...
(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at ... Oat is recognized globally as one of the healthiest cereals, XieQingkui, the founder of ... a move to sow the seed of good karma. Buddhism spirit featuring benevolence and ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 23. Januar 2017  ResMed (NYSE: RMD ... 3B Medical ( Winter Haven, Florida ) ... über die Beilegung aller globalen Rechtsstreitigkeiten zwischen den Parteien ... ihrer bestehenden Produkte im Tausch gegen Lizenzgebühren an ... 3B leisten, um das in Florida ...
(Date:1/22/2017)... , Saudi Arabia , January 22, 2017 ... US and UAE discuss ... at the World Economic Forum   "The management and ... big data and powered by artificial intelligence and this trend is going to ... ,Hospital of the Future, at the concluding day of the 47 th ...
(Date:1/21/2017)... , Jan. 20, 2017  Today, during ... Conference, "PI3K Pathways in Immunology, Growth Disorders ... (NASDAQ: INFI ) presented preclinical ... candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). Preclinical ... help overcome resistance to checkpoint inhibition by ...
Breaking Medicine Technology: